Skip to content
TrialScanner

NCT03941444

ANAVEX2-73 Study in Patients With Rett Syndrome

Phase 3CompletedAVXLLead

Registry record

Lead sponsor
Anavex Life Sciences Corp.
Conditions
Rett Syndrome
Primary completion
Sep 30, 2021Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT03941444 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT03941444: ANAVEX2-73 Study in Patients... | TrialScanner